ARCHIVES

Researchers Identify Mutation Linked to Inherited Risk of ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Institute Funds 24 DNA Microarray Centers

September 24, 1999

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

In Brief: NIH Reviewers, Advisors To Get Increase In Honoraria; Price Leaving NCI for Maryland

March 14, 1980

OMB Restriction On Reprogramming Threatens Grants Of Three Centers, Possible Restorations

June 6, 1986

New Community Control Program May Be Developed

October 24, 1975

Oncology Nurse “Cinderella’s” Need Specialty Status

November 23, 1974